KMT2A and acute myeloid leukemia: The median number of mutations per patient was 2.0 (range, 0 to 18), with the highest rate of mutations in cytogenetically normal AML (CN-AML) (3.0) and the lowest in KMT2A-rearranged AML (1.0).